These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 8627821

  • 1. Preoperative reverse transcriptase polymerase chain reaction for prostate specific antigen predicts treatment failure following radical prostatectomy.
    Olsson CA, de Vries GM, Raffo AJ, Benson MC, O'Toole K, Cao Y, Buttyan RE, Katz AE.
    J Urol; 1996 May; 155(5):1557-62. PubMed ID: 8627821
    [Abstract] [Full Text] [Related]

  • 2. Detection of micrometastatic prostate cancer cells in the lymph nodes by reverse transcriptase polymerase chain reaction is predictive of biochemical recurrence in pathological stage T2 prostate cancer.
    Okegawa T, Nutahara K, Higashihara E.
    J Urol; 2000 Apr; 163(4):1183-8. PubMed ID: 10737491
    [Abstract] [Full Text] [Related]

  • 3. Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score.
    Freedland SJ, Wieder JA, Jack GS, Dorey F, deKernion JB, Aronson WJ.
    J Urol; 2002 Jul; 168(1):110-5. PubMed ID: 12050502
    [Abstract] [Full Text] [Related]

  • 4. Can perineural invasion on prostate needle biopsy predict prostate specific antigen recurrence after radical prostatectomy?
    de la Taille A, Rubin MA, Bagiella E, Olsson CA, Buttyan R, Burchardt T, Knight C, O'Toole KM, Katz AE.
    J Urol; 1999 Jul; 162(1):103-6. PubMed ID: 10379750
    [Abstract] [Full Text] [Related]

  • 5. The value of a reverse transcriptase polymerase chain reaction assay in preoperative staging and followup of patients with prostate cancer.
    Ellis WJ, Vessella RL, Corey E, Arfman EW, Oswin MM, Melchior S, Lange PH.
    J Urol; 1998 Apr; 159(4):1134-8. PubMed ID: 9507816
    [Abstract] [Full Text] [Related]

  • 6. Detection of circulating prostate specific antigen expressing prostatic cells in the bone marrow of radical prostatectomy patients by sensitive reverse transcriptase polymerase chain reaction.
    Gao CL, Dean RC, Pinto A, Mooneyhan R, Connelly RR, McLeod DG, Srivastava S, Moul JW.
    J Urol; 1999 Apr; 161(4):1070-6. PubMed ID: 10081840
    [Abstract] [Full Text] [Related]

  • 7. Is preoperative serum prostate-specific antigen level significantly related to clinical recurrence after radical retropubic prostatectomy for localized prostate cancer?
    Haukaas SA, Halvorsen OJ, Daehlin L, Hostmark J, Akslen LA.
    BJU Int; 2006 Jan; 97(1):51-5. PubMed ID: 16336328
    [Abstract] [Full Text] [Related]

  • 8. Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy.
    Zhou M, Hayasaka S, Taylor JM, Shah R, Proverbs-Singh T, Manley S, Rubin MA.
    J Urol; 2001 Dec; 166(6):2193-7. PubMed ID: 11696734
    [Abstract] [Full Text] [Related]

  • 9. Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers.
    Noguchi M, Stamey TA, McNeal JE, Yemoto CM.
    J Urol; 2000 Nov; 164(5):1596-600. PubMed ID: 11025712
    [Abstract] [Full Text] [Related]

  • 10. Percent of cores positive for cancer is a better preoperative predictor of cancer recurrence after radical prostatectomy than prostate specific antigen.
    San Francisco IF, Regan MM, Olumi AF, DeWolf WC.
    J Urol; 2004 Apr; 171(4):1492-9. PubMed ID: 15017206
    [Abstract] [Full Text] [Related]

  • 11. Ultrasensitive detection of prostate specific antigen in the followup of 422 patients after radical prostatectomy.
    Haese A, Huland E, Graefen M, Hammerer P, Noldus J, Huland H.
    J Urol; 1999 Apr; 161(4):1206-11. PubMed ID: 10081870
    [Abstract] [Full Text] [Related]

  • 12. Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database.
    Freedland SJ, Aronson WJ, Terris MK, Kane CJ, Amling CL, Dorey F, Presti JC, SEARCH Database Study Group.
    J Urol; 2003 Jun; 169(6):2136-41. PubMed ID: 12771735
    [Abstract] [Full Text] [Related]

  • 13. Comparison of preoperative prostate specific antigen density and prostate specific antigen for predicting recurrence after radical prostatectomy: results from the search data base.
    Freedland SJ, Kane CJ, Presti JC, Terris MK, Amling CL, Dorey F, Aronson WJ.
    J Urol; 2003 Mar; 169(3):969-73. PubMed ID: 12576824
    [Abstract] [Full Text] [Related]

  • 14. Importance of margin extent as a predictor of outcome after adjuvant radiotherapy for Gleason score 7 pT3N0 prostate cancer.
    Valicenti RK, Chervoneva I, Gomella LG.
    Int J Radiat Oncol Biol Phys; 2004 Mar 15; 58(4):1093-7. PubMed ID: 15001249
    [Abstract] [Full Text] [Related]

  • 15. Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer.
    Kupelian P, Katcher J, Levin H, Zippe C, Klein E.
    Urology; 1996 Aug 15; 48(2):249-60. PubMed ID: 8753737
    [Abstract] [Full Text] [Related]

  • 16. The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
    Freedland SJ, Aronson WJ, Terris MK, Kane CJ, Amling CL, Dorey F, Presti JC.
    Cancer; 2003 Dec 01; 98(11):2344-50. PubMed ID: 14635068
    [Abstract] [Full Text] [Related]

  • 17. The relationship between the extent of surgical margin positivity and prostate specific antigen recurrence in radical prostatectomy specimens.
    Marks RA, Koch MO, Lopez-Beltran A, Montironi R, Juliar BE, Cheng L.
    Hum Pathol; 2007 Aug 01; 38(8):1207-11. PubMed ID: 17490720
    [Abstract] [Full Text] [Related]

  • 18. Mitochondrial DNA in serum of patients with prostate cancer: a predictor of biochemical recurrence after prostatectomy.
    Ellinger J, Müller SC, Wernert N, von Ruecker A, Bastian PJ.
    BJU Int; 2008 Aug 05; 102(5):628-32. PubMed ID: 18410441
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Preoperative blood reverse transcriptase-PCR assays for prostate-specific antigen and human glandular kallikrein for prediction of prostate cancer progression after radical prostatectomy.
    Shariat SF, Gottenger E, Nguyen C, Song W, Kattan MW, Andenoro J, Wheeler TM, Spencer DM, Slawin KM.
    Cancer Res; 2002 Oct 15; 62(20):5974-9. PubMed ID: 12384565
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.